Another Hybrid License Deal: Chiesi Buys Majority Stake In Cornerstone
This article was originally published in The Pink Sheet Daily
Executive Summary
With a would-be competitor from Discovery Labs stalled at FDA, approved lung surfactant Curosurf sits at the center of equity, cash tie-up.